Merck & Co., Inc. (MRK) Tops Q1 EPS by 2c, Revs Light; Reaffirms Outlook
Tweet
Share
E-mailGet Alerts MRK Hot Sheet
Price: $135.55 +1.98%
Financial Fact:
Equity income from affiliates: -2.5B
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Equity income from affiliates: -2.5B
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Merck & Co., Inc. (NYSE: MRK) reported Q1 EPS of $0.99, $0.02 better than the analyst estimate of $0.97. Revenue for the quarter came in at $11.73 billion versus the consensus estimate of $11.82 billion.
Merck & Co., Inc. reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Merck & Co., Inc. (MRK) click here.
Merck & Co., Inc. reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Merck & Co., Inc. (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Lument Finance Trust (LFT) Misses Q2 EPS by 17c
- 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
